Business Context and Reporting Period
Company: Superior Surgical Mfg. Co., Inc. (Superior Group of Companies, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1996
Business Overview: The company manufactures surgical products. Net sales increased due to new customers and new uniform programs.
Key Financial Metrics
| Metric | Q1 1996 | Q1 1995 |
|---|---|---|
| Net Sales | $34,672,192 | $34,116,921 |
| Net Earnings | $1,916,317 | $2,231,317 |
| Earnings Per Share | $0.24 | $0.27 |
| Operating Cash Flow | $6,011,981 | $2,629,675 |
| Cash and Certificates of Deposit | $9,653,225 | $11,190,311 |
| Total Debt (Current + Long-Term) | $18,600,000 | $18,600,000 |
| Cost of Goods Sold Margin | 66.7% | 66.7% |
Material Changes vs. Prior Period
- Revenue: Net sales increased slightly by approximately 1.6% compared to the prior year quarter.
- Profitability: Net earnings decreased 14% to $1,916,317. This decline was driven by increased selling and administrative expenses and a 36% increase in interest expense due to lower cash balances invested in certificates of deposit.
- Cash Flow: Net cash provided by operating activities more than doubled to $6.0 million, primarily due to favorable changes in accounts payable and receivables.
- Liquidity: Cash and certificates of deposit increased by $4.2 million during the quarter to $9.65 million.
- Inventory: Inventories increased 3% to $42.2 million to support expected customer demand.
Outlook, Risks, and Contingencies
Legal Proceedings and Settlement
The company has reached settlement agreements with the Department of Justice and the U.S. Attorney's Office regarding a federal criminal and civil investigation involving alleged false statements related to U.S. Department of Veterans Affairs contracts. Key terms include:
- Settlement Payment: $6,200,000 to resolve civil and contractual disputes.
- Criminal Penalty: $300,000 fine and a guilty plea by the company for one count of violating the Federal False Statements Act.
- Accrual: The company accrued $6,500,000 as of December 31, 1995, to cover these costs.
- Future Contracts: Management expects no restrictions on future federal contracts upon finalization of the agreements.
Management Commentary
Management believes cash flow from operations and available credit (including $10 million under a revolving credit agreement) are adequate to meet funding requirements for the remainder of the year. The company plans to continue its capital expenditure program to maintain and improve facilities.
Investor Verification Checklist
- Verify the final court approval of the $6.5 million legal settlement and confirm no additional charges arise.
- Monitor the impact of the guilty plea on the company's ability to secure future federal contracts with the Department of Veterans Affairs.
- Assess the sustainability of the 14% decline in net earnings given the rise in selling and administrative expenses.
- Confirm the utilization of the $10 million available revolving credit line.